Abstract Purpose The SARS‐CoV‐2 pandemic prompted the development and use of next‐
generation vaccines. Among these, mRNA‐based vaccines consist of injectable solutions of …

OBJECTIVE: COVID-19 patients experience, in 10-20% of the cases, a prolonged long-
COVID syndrome, defined as the persistence of symptoms for at least two months after the …

Serological tests play an essential role in monitoring and combating the COVID-19
pandemic. Recombinant spike protein (S protein), especially the S1 protein, is one of the …

A correct identification of seropositive individuals for the severe acute respiratory syndrome
coronavirus‐2 (SARS‐CoV‐2) infection is of paramount relevance to assess the degree of …

Due to the beginning of vaccination against COVID-19, serological discrimination between
vaccine-associated humoral response and serology-based surveillance of natural SARS …

The spike protein of SARS-CoV-2 has been found to exhibit pathogenic characteristics and
be a possible cause of post-acute sequelae after SARS-CoV-2 infection or COVID-19 …

The SARS-CoV-2 spike trimer is the primary antigen for several serology assays critical to
determining the extent of SARS-CoV-2 exposure in the population. Until stable cell lines are …

The recent outbreak of the betacoronavirus SARS-CoV-2 has become a significant concern
to public health care worldwide. As of August 19, 2020, more than 22,140,472 people are …

We describe scalable and cost‐efficient production of full length, His‐tagged severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) spike glycoprotein trimer by Chinese …

There is an urgent need for robust and high-throughput methods for SARS-CoV-2 detection
in suspected patient samples to facilitate disease management, surveillance, and control …